外高桥 (600648.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

7.4x

Market Cap

CNY 12.27B

MomentumView details →

1D Return

+0.33%

YTD Return

−7.53%

RSI (14)

63.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

7.4x

Market Cap

CNY 12.27B

RSI (14)

63.6

MomentumView details →

1D Return

+0.33%

YTD Return

−7.53%

ProfitabilityView details →

Gross Margin

28.29%

Net Margin

15.25%

EBITDA Margin

36.74%

ROE (TTM)

5.70%

ROA (TTM)

1.88%

Asset Turnover

0.12x

GrowthView details →

Revenue YoY

−18.25%

EPS YoY

−16.03%

FCF YoY

+39.41%

Revenue CAGR 3Y

−13.43%

EPS CAGR 3Y

−12.51%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.65x

Current Ratio

1.26x

Quick Ratio

0.52x

Div Yield

3.75%

Div Rate

CNY 0.35

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

5.96B

Net Income (TTM)

909.41M

Op. CF (TTM)

434.56M

Latest newsMore news →

On August 31, 2026, Shanghai Waigaoqiao Group visited Jiuzhoutong Pharmaceutical Group's Wuhan headquarters and the two parties signed a cooperation agreement covering biopharmaceutical industry ecosystem, cross-border expansion and ODI services, and industrial fund cooperation.3d ago

Similar companies

Guangdong - Hong Kong Greater Bay Area Holdings Limited01396.HK 南京高科600064.SH 香江控股600162.SH Yuexiu Property Company Limited00123.HK 中华企业600675.SH 浦东金桥600639.SH Find similar companies →

Latest newsMore news →

On August 31, 2026, Shanghai Waigaoqiao Group visited Jiuzhoutong Pharmaceutical Group's Wuhan headquarters and the two parties signed a cooperation agreement covering biopharmaceutical industry ecosystem, cross-border expansion and ODI services, and industrial fund cooperation.3d ago